Gaylan L Rockswold MD
Professor, Neurosurgery, University of Minnesota Medical School, Minneapolis
Join to View Full Profile
701 Park AveP5Minneapolis, MN 55415
Phone+1 612-873-2810
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gaylan Rockswold, MD is a neurosurgeon in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is a Professor at University of Minnesota Medical School.
Education & Training
University of MinnesotaResidency, Neurological Surgery, 1969 - 1974
Homewood Hospital Center - North CampusResidency, Surgery, 1967 - 1968
Hennepin HealthcareInternship, Transitional Year, 1966 - 1967- University of Minnesota Medical SchoolClass of 1966
Certifications & Licensure
MN State Medical License 1967 - 2025
American Board of Neurological Surgery Neurological Surgery
Publications & Presentations
PubMed
- Improved mortality analysis in early-phase dose-ranging clinical trials for emergency medical diseases using Bayesian time-to-event models with active comparators.Xiaosong Shi, Jo A Wick, Renee' L Martin, Jonathan Beall, Robert Silbergleit
Statistics in Medicine. 2024-08-30 - Selection of a statistical analysis method for the Glasgow Outcome Scale-Extended endpoint for estimating the probability of favorable outcome in future severe TBI cli...Yu Wang, Sharon D Yeatts, Renee' H Martin, Robert Silbergleit, Gaylan L Rockswold
Statistics in Medicine. 2023-11-10 - 3 citationsStatistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker ...Leonidas E Bantis, Kate J Young, John V Tsimikas, Brian R Mosier, Byron Gajewski
Research Methods in Medicine & Health Sciences. 2023-01-01
Press Mentions
Appointment of Dr. David Darrow to Hennepin Healthcare Endowed Chair Marks Renewed Era of CollaborationAugust 3rd, 2021
Phase II Clinical Trial of Combined HBO2/NBH Treatment for Severe Traumatic Brain InjuryFebruary 10th, 2016
Grant Support
- Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCCHENNEPIN HEALTHCARE RESEARCH INSTITUTE2024–2025
- Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCCHENNEPIN HEALTHCARE RESEARCH INSTITUTE2024–2025
- Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCCHENNEPIN HEALTHCARE RESEARCH INSTITUTE2024–2025
